NCT03450031View on ClinicalTrials.gov

Evaluation of Nasal Inflammatory Biomarkers

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

April 26, 2018

Study Completion Date

October 30, 2018

Conditions
Seasonal Allergic Rhinitis
Interventions
OTHER

NAC (no drug/no device)

Nasal allergen challenge (NAC) with mixed grass pollen: a bolus NAC with mixed grass pollen will be conducted

Trial Locations (1)

30165

Fraunhofer ITEM im CRC, Hanover

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Fraunhofer-Institute of Toxicology and Experimental Medicine

OTHER